Emmanuel Huynh
Président chez ABIONYX PHARMA
Profil
Emmanuel Huynh is the founder of H4 Orphan Pharma SAS, which was founded in 2016.
He is also the founder of Newcap SASU and Newcap SAS.
Dr. Huynh's current job positions include Chairman at ABIONYX Pharma SA, Chairman at Domundi SC, and Director & Vice President at Alfred Fournier Institute.
Dr. Huynh's education history includes an MBA from Sciences Po and a doctorate from Sorbonne Université.
Postes actifs de Emmanuel Huynh
| Sociétés | Poste | Début |
|---|---|---|
| ABIONYX PHARMA | Président | 12/09/2019 |
Newcap SASU
 Newcap SASU Miscellaneous Commercial ServicesCommercial Services Newcap SAS provides investor relations and strategic communication advisory services. It specializes in financial advertising, analyst relations, sectoral communication, media relations, institutional communication, initial public offering, and international market intelligence. The company was founded by Emmanuel Huynh and Pierre Laurent and is headquartered in Paris, France. | Directeur Général | - |
| Domundi SC | Président | - |
Alfred Fournier Institute
 Alfred Fournier Institute Medical/Nursing ServicesHealth Services Alfred Fournier Institute operates a medical center. The private company is based in Paris, France. | Directeur/Membre du Conseil | - |
Newcap SAS
 Newcap SAS Financial ConglomeratesFinance Newcap SAS is a specialist in investor relations and strategic communication consulting. Newcap is based in Paris, FR and was founded by Pierre Laurent and Emmanuel Huynh. The French company advises and supports its clients in their sector-based, scientific, institutional, and financial communication strategy. | Fondateur | - |
H4 Orphan Pharma SAS
 H4 Orphan Pharma SAS Pharmaceuticals: MajorHealth Technology H4 Orphan Pharma SAS engages in the development of pharmaceutical products for orphan diseases. It specializes in treatments for pulmonary idiopathic fibrosis, severe asthma, and chronic obstructive pulmonary disease. The company was founded on June 21, 2016 and is headquartered in Dijon, France. | Fondateur | 01/01/2016 |
Formation de Emmanuel Huynh
| Sciences Po | Masters Business Admin |
| Sorbonne Université | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| Entreprise privées | 5 |
|---|---|
Newcap SASU
Newcap SASU Miscellaneous Commercial ServicesCommercial Services Newcap SAS provides investor relations and strategic communication advisory services. It specializes in financial advertising, analyst relations, sectoral communication, media relations, institutional communication, initial public offering, and international market intelligence. The company was founded by Emmanuel Huynh and Pierre Laurent and is headquartered in Paris, France. | Commercial Services |
Alfred Fournier Institute
Alfred Fournier Institute Medical/Nursing ServicesHealth Services Alfred Fournier Institute operates a medical center. The private company is based in Paris, France. | Health Services |
Newcap SAS
Newcap SAS Financial ConglomeratesFinance Newcap SAS is a specialist in investor relations and strategic communication consulting. Newcap is based in Paris, FR and was founded by Pierre Laurent and Emmanuel Huynh. The French company advises and supports its clients in their sector-based, scientific, institutional, and financial communication strategy. | Finance |
H4 Orphan Pharma SAS
H4 Orphan Pharma SAS Pharmaceuticals: MajorHealth Technology H4 Orphan Pharma SAS engages in the development of pharmaceutical products for orphan diseases. It specializes in treatments for pulmonary idiopathic fibrosis, severe asthma, and chronic obstructive pulmonary disease. The company was founded on June 21, 2016 and is headquartered in Dijon, France. | Health Technology |
| Domundi SC |
